Embecta EMBC
NASDAQ EMBC
$6.43 +0.02 (+0.31%)
At close: Nov 10, 2026 · 4:00 PM EST

Embecta (EMBC) Non Operating Interest Expenses (2022)

Updated

Embecta (EMBC) reported Non Operating Interest Expenses of $4.9 million for fiscal Q2 2022 (quarter ended Mar 31, 2022).

Analysis

Embecta (EMBC) Non Operating Interest Expenses (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn 417.00 Mn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn 350.00 Mn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn 135.00 Mn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn -
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn 186.00 Mn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn 143.00 Mn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn 100.00 Mn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn -
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn -
10 Embecta 364.32 Mn -462.08 Mn 153.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 4.90 Mn
API Access

Embecta Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=EMBC&period=max&api_key=YOUR_API_KEY